Advertisement






Click here for more guidelines.
CME Topic Collections Past Issues Search Current Issue Home
     

J Am Coll Cardiol, 2004; 43:2177-2182, doi:10.1016/j.jacc.2004.02.052
© 2004 by the American College of Cardiology Foundation
This Article
Right arrow Abstract Freely available
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Sonntag, S.
Right arrow Articles by Kleber, F. X.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Sonntag, S.
Right arrow Articles by Kleber, F. X.

The calcium sensitizer levosimendan improves the function of stunned myocardium after percutaneous transluminal coronary angioplasty in acute myocardial ischemia

Steffen Sonntag*,*, Stig Sundberg, PhD{dagger}, Lasse Antero Lehtonen, MD{ddagger} and Franz Xaver Kleber, MD*

* UKB Berlin and Free University Berlin, Berlin, Germany
{dagger} Orion Corporation, Espoo, Finland
{ddagger} Helsinki University Central Hospital, Helsinki, Finland



View larger version (27K):

[in a new window]
 
Figure 1 An example of a pressure–volume loop of a patient receiving levosimendan is shown. Levosimendan caused a downward shift of the diastolic part of the pressure–volume loop. It is noteworthy that all shifts were only minor and the difference of frequency distribution between levosimendan and placebo was not significant. LVP = left ventricular pressure; LVV = left ventricular volume.

 


View larger version (16K):

[in a new window]
 
Figure 2 The mean pulmonary artery pressure (mPAP) and mean pulmonary capillary wedge pressure (mPCWP) were decreased by levosimendan. In addition, the left ventricular end-systolic and end-diastolic volume indexes (LVESVI and LVEDVI) were decreased by levosimendan, whereas the left ventricular ejection fraction (LVEF) was increased. *p ≤ 0.05. **p ≤ 0.01.

 




 
  CME Topic Collections Past Issues Search Current Issue Home

Advertisement